SEC 8-K and 6-K filings classified by Claude with reasoning, plus Form 4 insider transactions. Ingested from EDGAR’s filing stream in near-real time, reconciled overnight.
Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
The Company created a direct financial obligation of $2.5M under the ACM Letter Agreement and Confession of Judgment, signaling an accelerated or triggered obligation that reflects material financial distress.
View raw filing on EDGAR →A court order vacated a temporary restraining order and scheduled a fairness hearing for a settlement agreement conditioning issuance of settlement shares, and the Company terminated placement agent agreements with Aegis Capital in exchange for $2 million in contingent consideration securities.
View raw filing on EDGAR →This is a clear Item 5.07 disclosure of shareholder meeting results held on May 19, 2026. The filing reports voting outcomes on three proposals: election of nine trustees, ratification of KPMG LLP as independent auditor, and advisory approval of executive compensation. The detailed vote tallies (For, Against/Withheld, Abstentions, Broker Non-Votes) for each proposal are the core content of the filing, matching the shareholder_vote_results taxonomy precisely.
View raw filing on EDGAR →Novelis Inc. issued a press release on May 19, 2026 reporting financial results for its fiscal year ended March 31, 2026, with the press release attached as Exhibit 99.1. The Item 2.02 disclosure explicitly states the company is furnishing results of operations and financial condition, which is the standard format for earnings releases. The detailed non-GAAP reconciliations (Adjusted EBITDA, Adjusted Free Cash Flow, Net Income Excluding Special Items) are typical of annual earnings disclosures.
View raw filing on EDGAR →Roblox announced a $3 billion share repurchase program authorized by its Board of Directors. While share buybacks are material capital allocation decisions that affect shareholder value and earnings per share, this disclosure does not fit neatly into the more specific event categories (it is not an earnings release, M&A activity, executive change, or financial restatement). The authorization itself—distinct from actual repurchases—is a significant corporate action that would inform investor assessment of capital strategy, but the taxonomy lacks a dedicated "capital allocation" or "buyback authorization" category.
View raw filing on EDGAR →This 8-K Item 2.03 discloses the creation of direct financial obligations through the issuance of consolidated obligation bonds totaling $50 million across three tranches (maturing 2027–2031 with coupons of 4.0–4.35%). While Item 2.03 typically signals covenant_breach or debt acceleration events, this filing describes routine debt issuance by a Federal Home Loan Bank in the capital markets—a material but recurring operational activity that does not fit the specific covenant_breach taxonomy (which implies default or acceleration). The Bank explicitly notes that "consolidated obligations issuance is material to the Bank" but disclaims judgment on individual issuances' materiality, suggesting this is standard disclosure practice rather than an extraordinary event.
View raw filing on EDGAR →AtriCure held its Annual Meeting of Stockholders on May 19, 2026, with shareholders voting on five proposals including director elections, auditor ratification, stock plan amendments, and an advisory compensation vote. All proposals passed with substantial majorities.
View raw filing on EDGAR →This disclosure reports the creation of direct financial obligations through the issuance of consolidated obligations (bonds and discount notes) by the Federal Home Loan Bank of Des Moines. While Item 2.03 typically captures covenant breaches or material debt arrangements, this filing describes routine debt issuance activity that is material to the Bank's operations but does not fit cleanly into the covenant_breach category (no breach or default is disclosed). The Bank explicitly states "consolidated obligations issuance is material to the Bank," and Schedule A details committed issuances, making this a material event that warrants disclosure but falls outside the more specific event-type categories.
View raw filing on EDGAR →This 8-K Item 2.03 discloses the creation of direct financial obligations through the issuance of consolidated obligations (bonds and discount notes) totaling approximately $960 million across five separate issuances in May 2026. While the filing explicitly states "consolidated obligations issuance is material to the FHLBank," the disclosure does not fit cleanly into the standard taxonomy categories. The event is a routine debt issuance by a government-sponsored enterprise (Federal Home Loan Bank), not a covenant breach, M&A activity, or other more specific event type. This is best classified as other_material given its materiality to the registrant's funding operations and balance sheet, despite being a standard capital markets activity.
View raw filing on EDGAR →This Item 2.03 disclosure reports the issuance of Consolidated Bonds (debt securities) totaling $81 million across six bond offerings on trade date 5/13/2026. While Item 2.03 is technically designated for "Creation of a Direct Financial Obligation," the filing itself explicitly states "although Consolidated Obligations issuance is material to the FHLB, we have not made a judgment as to the materiality of any particular Consolidated Obligation or Obligations." The disclosure is routine debt issuance reporting by a Federal Home Loan Bank, not a material event in the traditional 8-K sense (no covenant breach, no going-concern issue, no acceleration of obligations). This is a borderline case—the issuance is material in aggregate to the FHLB's operations, but the filing's own language suggests individual issuances are routine capital-markets activity. Classified as other_material rather than covenant_breach because no triggering event or financial stress is disclosed.
View raw filing on EDGAR →This Item 2.03 disclosure reports the issuance of consolidated obligation bonds totaling approximately $260 million across nine separate debt securities issued on trade dates of 5/13/2026 and 5/15/2026. While Item 2.03 is technically designated for "Creation of a Direct Financial Obligation," the filing itself explicitly states "although consolidated obligations issuance is material to the Bank, we have not made a judgment as to the materiality of any particular consolidated obligation or obligations." The disclosure is routine debt issuance reporting for a Federal Home Loan Bank, which regularly accesses capital markets through consolidated obligations. This does not fit the specific event types of covenant_breach (no breach indicated), ma_activity (no acquisition/merger), or other more specific categories—it is a material but routine debt issuance disclosure.
View raw filing on EDGAR →This Item 2.03 disclosure reports the creation of direct financial obligations through the issuance of consolidated obligations (bonds and discount notes) totaling approximately $2.185 billion across multiple tranches with varying maturities, rates, and call features. While Item 2.03 typically signals covenant_breach or debt acceleration events, this filing discloses routine debt issuances by a Federal Home Loan Bank in the ordinary course of business—a material but recurring funding activity. The disclosure emphasizes joint and several liability across all FHLBanks and provides detailed Schedule A information on each issuance, making it material to investors but not fitting the specific covenant_breach or other narrower event categories.
View raw filing on EDGAR →This 8-K Item 2.03 discloses the creation of direct financial obligations through the issuance of consolidated obligations (debt securities) totaling $850 million across three tranches with trade dates of 5/15/2026 and 5/19/2026. While Item 2.03 is the designated item for debt issuances, the taxonomy lacks a specific "debt_issuance" category. The filing explicitly states "consolidated obligations issuance is material to the Bank," and these obligations represent direct financial liabilities. This is classified as "other_material" rather than "covenant_breach" (which addresses defaults) because it represents routine debt capital-raising activity, albeit material in amount, that does not fit the more specific event categories provided.
View raw filing on EDGAR →The filing discloses the Federal Home Loan Bank of Indianapolis becoming the primary obligor on consolidated obligation bonds totaling approximately $445 million across multiple issuances with varying maturities (2028–2056) and rate structures. While Item 2.03 is technically about creation of direct financial obligations, this disclosure is most accurately characterized as a material debt issuance event. The bonds are joint and several obligations of the FHLBanks and represent a significant financial commitment, but the filing does not fit cleanly into the covenant_breach taxonomy (no breach alleged) or other more specific event types, making other_material the most appropriate classification.
View raw filing on EDGAR →This 8-K Item 2.03 discloses the creation of direct financial obligations through the issuance of consolidated obligation bonds totaling approximately $920.2 million across multiple tranches with varying maturities (2026–2036) and rate structures. While the Bank explicitly states it "has not made a judgment as to the materiality of these consolidated obligation bonds," the aggregate principal amount and the nature of debt issuance—a core funding mechanism for a Federal Home Loan Bank—constitute a material event affecting the registrant's financial position. This does not fit neatly into the covenant_breach taxonomy (no breach disclosed) but represents a material creation of direct financial obligations as contemplated by Item 2.03.
View raw filing on EDGAR →Healthcare Realty Trust entered into a $400 million senior unsecured delayed draw term loan facility on May 15, 2026, with Wells Fargo as administrative agent and a syndicate of major lenders, maturing in May 2029. While structured as a financing arrangement rather than a traditional M&A transaction, this material definitive agreement substantially affects the company's capital structure and financial obligations.
View raw filing on EDGAR →DHI Group held its Annual Meeting on May 15, 2026, at which shareholders voted on five proposals: election of two Class I directors (Art Zeile and Elizabeth Salomon), ratification of RSM US LLP as auditor, advisory vote on named executive officer compensation, and approval of amendments to the 2022 Omnibus Equity Award Plan and 2020 Employee Stock Purchase Plan. All proposals were approved by shareholders.
View raw filing on EDGAR →The filing discloses that WBD's subsidiaries have commenced consent solicitations to amend indentures governing outstanding notes in connection with the pending acquisition of WBD by Paramount Skydance Corporation. While the primary focus is the consent solicitation mechanics, the disclosure is fundamentally tied to and conditioned upon the material acquisition transaction. The forward-looking statements section explicitly references "the acquisition of WBD (the 'Acquisition') by Paramount Skydance Corporation" as a central transaction affecting the company's financial obligations and future operations, making this a material M&A-related event.
View raw filing on EDGAR →Granite Construction announced pricing of a $600 million private offering of senior notes due 2034. While this is a material debt issuance that would affect investor assessment of the company's capital structure and financial obligations, it does not fit cleanly into the dilutive_issuance category (which focuses on equity securities) nor any other specific event type. The disclosure is material as it represents a significant financing activity, but the taxonomy lacks a dedicated debt issuance category.
View raw filing on EDGAR →The filing discloses financial results for the fiscal quarter ended March 31, 2026 via a press release issued on May 14, 2026, filed under Item 2.02 (Results of Operations and Financial Condition). This is a standard quarterly earnings release, which is material to investors as it provides key financial performance metrics.
View raw filing on EDGAR →The Company entered into a Memorandum of Understanding with the County of Maui regarding the sale or lease of real property and water infrastructure assets in West Maui and Upcountry Maui. Although the MOU is non-binding, it represents a material disposition of assets (water-related assets and real property) that would affect a reasonable investor's assessment of the Company's strategic direction and asset base. The disclosure emphasizes this as "an important milestone in the Company's efforts to sell certain assets" and notes the County has "initiated budget allocations toward the potential purchase," indicating substantive progress toward a material transaction.
View raw filing on EDGAR →Sypris Solutions disclosed financial results for the first quarter ended April 5, 2026, announced on May 19, 2026, with the full press release furnished as Exhibit 99 under Regulation FD.
View raw filing on EDGAR →Kingsway Financial Services Inc. changed its corporate name to Kingsway Corporation and its ticker symbol to 'KWY' on the NYSE, effective May 19, 2026, following shareholder approval and amendments to the Certificate of Incorporation and Bylaws.
View raw filing on EDGAR →The filing discloses a sale of three nonperforming loans via press release on May 19, 2026. While loan sales can be routine portfolio management, the fact that Alerus Financial chose to announce this via 8-K Item 8.01 suggests materiality to investors. However, without details on the dollar amount, impact on asset quality, or strategic significance, the event does not clearly fit the more specific categories (e.g., material_impairment would require a write-down or charge; ma_activity typically involves larger acquisitions or dispositions). The disclosure is material enough to warrant 8-K filing but ambiguous in nature, making "other_material" the most appropriate classification.
View raw filing on EDGAR →This is a clear disclosure of shareholder vote results from Waterstone Financial's 2026 Annual Meeting of Shareholders held on May 19, 2026. The filing presents detailed voting tallies for four proposals: election of three directors, ratification of auditors (Forvis Mazars, LLP), advisory approval of executive compensation, and advisory vote on compensation voting frequency. This is a quintessential Item 5.07 shareholder_vote_results event, and the outcomes are material to investors as they reflect shareholder approval of board composition, auditor selection, and executive compensation arrangements.
View raw filing on EDGAR →This is a clear disclosure of shareholder vote results from Cathay General Bancorp's May 18, 2026 Annual Meeting of Stockholders. The filing reports voting outcomes on four matters: election of four Class III directors, advisory approval of executive compensation, frequency of future advisory votes on compensation, and ratification of KPMG LLP as independent auditor. The detailed vote tallies (for, against, abstain, broker non-votes) for each proposal are the core content of Item 5.07, which is the standard Item for reporting shareholder meeting results.
View raw filing on EDGAR →Eton entered into and completed a material supply and distribution agreement with Knight Therapeutics on May 18, 2026, acquiring exclusive U.S. commercialization rights to IMPAVIDO® (miltefosine). The transaction includes $4.25 million in fixed fees through March 31, 2032, up to $4.0 million in milestone payments, and royalties of 50–55% of net sales, directly expanding Eton's product portfolio with an orphan drug that generated $8.1 million in U.S. sales in 2025.
View raw filing on EDGAR →Moving iMAGE Technologies disclosed financial results for Q1 2026 (three months ended March 31, 2026) via press release and conference call transcript attached as exhibits.
View raw filing on EDGAR →GeoVax Labs entered into a securities purchase agreement on May 18, 2026 for an unregistered private placement of pre-funded warrants and common warrants to purchase up to 6,081,081 shares of common stock, raising approximately $2.7 million in net proceeds under Section 4(a)(2) and Regulation D exemptions. The offering was announced via press release and will substantially increase share count upon warrant exercise, materially diluting existing shareholders.
View raw filing on EDGAR →This is a classic Item 5.07 disclosure reporting the results of Rush Enterprises' 2026 Annual Meeting of Shareholders. The filing presents voting outcomes for three proposals: election of nine directors, advisory approval of executive compensation, and ratification of Ernst & Young LLP as independent auditor. The detailed vote tallies (votes for, against, withheld, and broker non-votes) are the core content, making this unambiguously a shareholder vote results disclosure.
View raw filing on EDGAR →Super League Enterprise issued a press release and hosted an earnings call on May 15, 2026 to announce financial results for the quarter ended March 31, 2026.
View raw filing on EDGAR →Monopar disclosed positive Phase 2 clinical trial results for ALXN1840 in Wilson disease via press release under Item 7.01 (Regulation FD Disclosure). While this is clinical progress material to investors in a biopharmaceutical company, it does not fit the "earnings_release" category (which typically covers financial results) and lacks the specificity of other event types. The disclosure of material clinical trial outcomes is a significant corporate event but is best classified as "other_material" given the taxonomy's focus on financial and governance events.
View raw filing on EDGAR →SiTime Corporation filed this 8-K to disclose financial statements and pro forma information related to its acquisition of Renesas Electronics' Timing Product Business, which was previously announced on February 4, 2026 via Asset Purchase Agreement. The filing includes audited and unaudited combined financial statements of the acquired business and pro forma combined financial information showing the impact of the acquisition, which are material disclosures required under Regulation S-X for significant acquisitions.
View raw filing on EDGAR →The filing discloses consolidated financial results for the fourth quarter and fiscal year ended March 31, 2026, via a press release attached as Exhibit 99.1. This is a standard earnings release disclosure under Item 2.02, which is material to investors as it provides periodic financial performance information.
View raw filing on EDGAR →The filing discloses that Wellgistics Health issued a press release on May 15, 2026 announcing it will report financial results for Q1 2026 on May 19, 2026 after market close. Item 7.01 explicitly references the press release furnished as Exhibit 99.1. This is a standard earnings announcement disclosure, which is material to investors as it signals the timing of quarterly financial results.
View raw filing on EDGAR →The filing discloses Amendment #2 to a Promissory Note with Streeterville Capital, LLC, extending the maturity date from June 30, 2026 to June 30, 2027 and adding a $10,000 extension fee. While the amendment itself is a negotiated modification rather than a breach, the need for a second extension of a debt obligation within approximately 16 months signals financial stress and inability to repay on the original schedule. The outstanding balance of $1,682,676.16 and repeated extensions suggest the company is managing liquidity constraints, which is material to investors assessing solvency risk.
View raw filing on EDGAR →PHP Ventures Acquisition Corp. disclosed under Item 8.01 that it deposited $957.30 into its trust account to extend the deadline for completing an initial business combination from May 16, 2026 to June 16, 2026. This is a material event for a SPAC seeking to extend its business combination deadline, as it directly affects the registrant's ability to consummate a transaction and avoid liquidation. However, the event does not fit neatly into the standard taxonomy categories (not M&A completion, not going concern, not a covenant breach), warranting classification as other_material.
View raw filing on EDGAR →Lipocine announced that its LPCN 1154 Phase 3 clinical trial data has been accepted for oral presentation at the 2026 ASCP Annual Meeting (May 26-29, 2026). This represents a material clinical development milestone for a biopharmaceutical company, as Phase 3 data acceptance for oral presentation at a major medical conference signals positive trial results and advances the drug candidate toward potential regulatory approval. While this does not fit neatly into the standard event taxonomy (not an earnings release, M&A activity, executive change, or other specifically enumerated categories), it is material to investors evaluating the company's pipeline and prospects.
View raw filing on EDGAR →Leviston converted $4 million of principal under a convertible note into 2,500,000 shares of Common Stock between May 12-18, 2026. This is a dilutive equity issuance resulting from debt conversion, which materially increases share count and dilutes existing shareholders. The conversion of a substantial debt obligation into equity is a material capital structure event.
View raw filing on EDGAR →The filing discloses a corporate rebranding from "Off The Hook YS Inc." to "NextBoat" and a ticker symbol change from OTH to NXB, disclosed under Item 7.01 (Regulation FD Disclosure). While a rebranding and ticker change would affect investor recognition and trading of the security, this does not fit neatly into the specific event categories (not an earnings release, executive change, M&A, impairment, or other defined material events). This is material to investors as it affects the company's public identity and trading symbol, but is best classified as other_material.
View raw filing on EDGAR →The filing discloses that on May 19, 2026, JFB Construction Holdings received the required shareholder written consent (from Joseph F. Basile, III and The Basile Family Irrevocable Trust) to approve the merger with Xtend AI Robotics, Inc. under the Merger Agreement dated February 13, 2026 (as amended March 21, 2026). This satisfies a critical closing condition for the transaction, which is expected to close in mid-2026. This is a material acquisition/change of control event that would significantly affect investor assessment of the registrant.
View raw filing on EDGAR →Zhe Zhang, a member of the Board of Directors and audit committee member, resigned effective immediately on May 18, 2026. The filing discloses a director departure under Item 5.02, which is material to investors as it affects board composition and audit committee oversight of a SPAC (special purpose acquisition company).
View raw filing on EDGAR →The filing discloses a 1-for-40 reverse stock split of AiRWA Inc.'s common stock, effective May 18, 2026, pursuant to a Certificate of Amendment filed with Delaware. While reverse stock splits are typically administrative in nature, this event is material to investors as it affects share structure, trading price, and market capitalization presentation. The disclosure does not fit neatly into the more specific event categories (not an earnings release, executive change, M&A, restatement, or other defined material events), making "other_material" the most appropriate classification.
View raw filing on EDGAR →The 8-K discloses results of Onity Group Inc.'s Annual Meeting of Shareholders held on May 19, 2026, under Item 5.07. The filing reports voting outcomes for three proposals: election of seven directors, ratification of Deloitte & Touche LLP as independent auditor, and advisory approval of named executive officer compensation, with specific vote tallies for each. This is a standard shareholder vote results disclosure that is material to investors as it confirms board composition and auditor appointment.
View raw filing on EDGAR →Power REIT announced a one-for-ten reverse stock split approved by its Board of Directors, effective June 2, 2026. While reverse stock splits are routine capital structure adjustments that do not affect relative ownership or voting rights, they are material corporate actions that affect share price, trading mechanics, and investor holdings. This disclosure does not fit neatly into the specific event categories (not an earnings release, executive change, M&A, impairment, or covenant breach), making "other_material" the most appropriate classification for a significant but non-standard corporate event.
View raw filing on EDGAR →The filing discloses that Class II directors Jeff Ervin and Jay Roberts will not seek re-election, and Jeff Hargroves resigned as a Class I director. While Hargroves was immediately re-appointed as a Class II director, the net effect is a reduction in board size from six to five directors and a departure of two sitting directors (Ervin and Roberts). The principal disclosed action centers on directors leaving their positions, making exec_departure the most salient classification, though the reclassification of Hargroves creates some ambiguity about whether this is primarily a departure or appointment event.
View raw filing on EDGAR →Enovis held its May 19, 2026 Annual Meeting of stockholders and disclosed voting results on four proposals: election of ten directors, ratification of Ernst & Young LLP as independent auditor, advisory vote on named executive officer compensation, and approval of an amendment to the 2020 Omnibus Incentive Plan authorizing an additional 3,650,000 shares and increasing director compensation limits from $350,000 to $750,000.
View raw filing on EDGAR →The filing discloses Amendment No. 4 to a Merger Agreement dated May 19, 2026, extending the Outside Closing Date from June 15, 2026 to December 19, 2026. This is a material amendment to an ongoing merger transaction involving Bayview Acquisition Corp and multiple parties including Oabay Holding Company and BLAFC Limited. The extension of the closing deadline is a significant modification to the material acquisition contemplated under Item 1.01.
View raw filing on EDGAR →The filing discloses entry into a $3.0 million secured promissory note with Streeterville Capital on May 13, 2026, reported under Item 1.01 (Entry into a Material Definitive Agreement). While Item 1.01 typically covers M&A transactions, this is a debt financing arrangement with extensive covenants, security interests in substantially all assets, and trigger events that could accelerate repayment—characteristics more aligned with a material financing obligation than a traditional M&A activity. The covenant restrictions and secured nature suggest this is a distressed or highly structured financing rather than a standard debt issuance.
View raw filing on EDGAR →The 8-K discloses a press release issued on May 19, 2026 (Exhibit 99.1) under Item 2.02 (Results of Operations and Financial Condition) and Item 7.01 (Regulation FD Disclosure). While the actual press release content is not provided in this excerpt, the filing structure—press release attached as exhibit under Item 2.02—is the standard format for earnings releases. The forward-looking statements language and reference to financial performance and growth opportunities further support this classification, though without seeing the exhibit itself, there remains some uncertainty about whether this is a full earnings release or a more limited financial update.
View raw filing on EDGAR →